PTC THERAPEUTICS, INC. Logo

PTC THERAPEUTICS, INC.

Develops and commercializes pioneering medicines for patients with rare diseases.

PTCT | US

Overview

Corporate Details

ISIN(s):
US69366J2006
LEI:
Country:
United States of America
Address:
500 WARREN CORPORATE CENTER DRIVE, 7059 WARREN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PTC Therapeutics, Inc. is a global biopharmaceutical company that discovers, develops, and commercializes clinically differentiated medicines for children and adults with rare diseases and high unmet medical needs. The company's research focuses on innovative platforms, including splicing modulation and targeting inflammation and ferroptosis pathways for central nervous system diseases. PTC has brought several pioneering therapies to market, including the world's first approved treatment for Duchenne muscular dystrophy, the first gene therapy directly infused into the brain, and the first approved small molecule splicing modifier. The company leverages its ability to identify new therapies and globally commercialize products to invest in a diversified clinical pipeline.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PTC THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PTC THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PTC THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HLB SCIENCE Inc. Logo
Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.
South Korea 343090
H. Lundbeck A Logo
Develops and commercializes innovative therapeutics for brain diseases globally.
Denmark HLUN
Hoth Therapeutics, Inc. Logo
Advancing therapeutics for metabolic, dermatologic, and inflammatory diseases.
United States of America HOTH
Global provider of medical aesthetic solutions like botulinum toxin and HA fillers.
South Korea 145020
Humacyte, Inc. Logo
Bioengineering off-the-shelf human tissues for vascular repair and regenerative medicine.
United States of America HUMA
Human Stem Cells Institute PJSC Logo
A biotech investor developing gene therapy, regenerative medicine, and genetic services.
Russian Federation ISKJ
HUMASIS CO., LTD. Logo
Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.
South Korea 205470
Humedix Co., Ltd. Logo
Develops hyaluronic acid-based pharma, aesthetics, medical devices, and offers CMO services.
South Korea 200670
HUONS CO., LTD. Logo
Global healthcare company providing pharmaceuticals, medical devices, and wellness products.
South Korea 243070
Huons Global Co., Ltd. Logo
Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.
South Korea 084110

Talk to a Data Expert

Have a question? We'll get back to you promptly.